<?xml version="1.0" encoding="UTF-8"?>
<ref id="ref-27">
 <label>Kang etÂ al. (2012)</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Kang</surname>
    <given-names>J</given-names>
   </name>
   <name>
    <surname>Zhang</surname>
    <given-names>Y</given-names>
   </name>
   <name>
    <surname>Cao</surname>
    <given-names>X</given-names>
   </name>
   <name>
    <surname>Fan</surname>
    <given-names>J</given-names>
   </name>
   <name>
    <surname>Li</surname>
    <given-names>G</given-names>
   </name>
   <name>
    <surname>Wang</surname>
    <given-names>Q</given-names>
   </name>
   <name>
    <surname>Diao</surname>
    <given-names>Y</given-names>
   </name>
   <name>
    <surname>Zhao</surname>
    <given-names>Z</given-names>
   </name>
   <name>
    <surname>Luo</surname>
    <given-names>L</given-names>
   </name>
   <name>
    <surname>Yin</surname>
    <given-names>Z</given-names>
   </name>
  </person-group>
  <year>2012</year>
  <article-title>Lycorine inhibits lipopolysaccharide-induced iNOS and COX-2 up-regulation in RAW264.7 cells through suppressing P38 and STATs activation and increases the survival rate of mice after LPS challenge</article-title>
  <source>International Immunopharmacology</source>
  <volume>12</volume>
  <issue>1</issue>
  <fpage>249</fpage>
  <lpage>256</lpage>
  <pub-id pub-id-type="doi">10.1016/j.intimp.2011.11.018</pub-id>
  <pub-id pub-id-type="pmid">22155741</pub-id>
 </element-citation>
</ref>
